Edition:
United States

Quest Diagnostics Inc (DGX)

DGX on New York Consolidated

93.51USD
17 Nov 2017
Change (% chg)

$0.57 (+0.61%)
Prev Close
$92.94
Open
$92.63
Day's High
$93.71
Day's Low
$92.02
Volume
518,793
Avg. Vol
1,119,853
52-wk High
$112.96
52-wk Low
$84.58

Latest Key Developments (Source: Significant Developments)

FDA approves Clinical Genomics, Quest Diagnostics Insure One
Monday, 13 Nov 2017 08:00am EST 

Nov 13 (Reuters) - Quest Diagnostics Inc :Clinical Genomics and Quest Diagnostics announce FDA 510(k) clearance of Insure® One™.Quest Diagnostics Inc- ‍insure One is expected to be commercially available in early 2018​.  Full Article

Quest Diagnostics acquires certain assets of California Laboratory Associates
Monday, 30 Oct 2017 06:45am EDT 

Oct 30 (Reuters) - Quest Diagnostics Inc :Quest Diagnostics acquires California Laboratory Associates.Quest Diagnostics Inc - ‍financial terms of agreement were not disclosed.​.Quest Diagnostics Inc - ‍it has acquired certain assets of California Laboratory Associates, a clinical lab network​.  Full Article

Advantage Capital Portfolio company Cleveland Heartlab acquired by Quest Diagnostics
Thursday, 19 Oct 2017 04:17pm EDT 

Oct 19 (Reuters) - Quest Diagnostics Inc :Advantage Capital Portfolio company Cleveland Heartlab, Inc acquired by Quest Diagnostics.‍cleveland Heartlab says Quest to maintain Cleveland Heartlab's clinic location in Cleveland's midtown area.  Full Article

Quest Diagnostics reports Q3 diluted eps of $1.15
Thursday, 19 Oct 2017 06:45am EDT 

Oct 19 (Reuters) - Quest Diagnostics Inc ::Quest Diagnostics reports third quarter 2017 financial results, updates 2017 financial guidance and reaffirms long term outlook.qtrly ‍adj earnings per share $1.39​.‍q3 reported diluted eps of $1.15​.Reports q3 revenue $1.93 billion.Reports q3 revenue up 2.4 percent.‍reaffirms long term outlook for 2017-2020​.‍2017 cash provided by operations remains at approximately $1.2 billion​.‍updates outlook for full year 2017 primarily due to financial impact of hurricanes and recently closed acquisitions in q3​.‍2017 reported revenues now expected to be approximately $7.71 billion​.‍continue to "urge" cms to delay implementation of protecting access to medicare act "to take time to get it right"​.‍2017 reported diluted eps now expected to be between $4.87 and $4.92​.2017 ‍adjusted diluted eps excluding amortization expense now expected to be between $5.62 and $5.67​.Fy2017 earnings per share view $5.63, revenue view $7.69 billion -- Thomson Reuters I/B/E/S.Q3 earnings per share view $1.35, revenue view $1.92 billion -- Thomson Reuters I/B/E/S.  Full Article

Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care
Thursday, 28 Sep 2017 07:30am EDT 

Sept 28 (Reuters) - Quest Diagnostics Inc :Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care.Quest Diagnostics Inc says financial terms were not disclosed..Says ‍transaction is structured as a purchase of assets.​.Quest Diagnostics Inc says transaction is expected to be completed in Q4 of 2017, subject to customary regulatory approvals.Quest Diagnostics - ‍Fresenius Medical Care's dialysis-related laboratory services business, Spectra Labs, is not affected by divestiture​.  Full Article

Quest Diagnostics provides update on impact to 3rd quarter financial results from hurricanes
Wednesday, 27 Sep 2017 04:15pm EDT 

Sept 27 (Reuters) - Quest Diagnostics Inc :Quest Diagnostics provides update on impact to third quarter financial results from hurricanes.Quest Diagnostics Inc- expects a reduction in revenues of about 1.5 pct due to recent hurricanes in Q3 2017.Quest Diagnostics Inc- expects a reduction in both reported EPS and adjusted diluted earnings per share of about $0.10 due to recent hurricanes in Q3.Quest diagnostics Inc- excluding anticipated impact of hurricanes in Q3, company reaffirms 2017 guidance provided on July 25, 2017.  Full Article

Oxford Immunotec announces update in patent infringement litigation
Wednesday, 27 Sep 2017 09:25am EDT 

Sept 27 (Reuters) - Oxford Immunotec Global Plc :Oxford Immunotec announces update in patent infringement litigation.Says ‍court denied company's motion​.Says ‍court further noted that if co "prevails at trial, it is likely that infringing aspects of qft plus will be permanently enjoined"​.Says ‍court believed company was not likely to suffer irreparable harm from qft-plus during few months remaining before trial​.  Full Article

Quest Diagnostics says qtrly adjusted earnings per share $1.55
Tuesday, 25 Jul 2017 08:23am EDT 

July 25 (Reuters) - Quest Diagnostics Inc :Reports Q2 revenue of $1.94 billion.Reports Q2 revenue up 1.9 percent on a reported basis.Quest diagnostics reports second quarter 2017 financial results, raises 2017 financial outlook.Raises 2017 financial outlook.Quest diagnostics inc sees ‍2017 capital expenditures $250 million to $300 million​.Qtrly earnings per share $1.37.Quest diagnostics inc -2017 ‍reported diluted eps now expected to be between $4.90 and $5.00​.Qtrly adjusted earnings per share $1.55.Qtrly adjusted diluted eps excluding amortization expense now expected to be between $5.62 and $5.72​.Qtrly net revenues $1,943 million versus $1,906 million.Ccash provided by operations now expected to be approximately $1.2 billion for 2017​.Q2 earnings per share view $1.42 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $5.57 -- Thomson Reuters I/B/E/S.Q2 revenue view $1.94 billion -- Thomson Reuters I/B/E/S.Sees fy 2017 revenues $7.69 billion to $7.74 billion.Fy2017 revenue view $7.69 billion -- Thomson Reuters I/B/E/S.  Full Article

Quest Diagnostics to acquire Cape Cod Healthcare outreach laboratory business
Tuesday, 27 Jun 2017 01:01pm EDT 

June 27 (Reuters) - Quest Diagnostics Inc :Quest Diagnostics announces intent to acquire Cape Cod Healthcare outreach laboratory business in Massachusetts.Quest Diagnostics Inc - signed a nonbinding letter of intent to acquire outreach laboratory services business of Cape Cod Healthcare.Quest Diagnostics Inc - financial terms were not disclosed..Quest Diagnostics Inc - acquisition is subject to review by Massachusetts health policy commission and completion of a definitive agreement.Quest Diagnostics Inc - upon approval by HPC, organizations expect to complete transaction by January 1, 2018.Quest Diagnostics Inc - CCHC's hospital-based laboratories and inpatient and outpatient services it provides are not included in transaction.Quest diagnostics inc - the two organizations also intend to explore opportunities to collaborate in population health and data analytics.  Full Article

Oxford Immunotec announces favorable claim construction ruling in patent infringement litigation
Thursday, 15 Jun 2017 04:05pm EDT 

June 15 (Reuters) - Oxford Immunotec Global Plc : :Oxford Immunotec announces favorable claim construction ruling in patent infringement litigation.Oxford Immunotec- favorable Markman claim construction ruling by judge in patent infringement lawsuit against Qiagen,Quest Diagnostics,Laboratory Corp.  Full Article

BRIEF-FDA approves Clinical Genomics, Quest Diagnostics Insure One

* Clinical Genomics and Quest Diagnostics announce FDA 510(k) clearance of Insure® One™